Biolase, Inc. · OTC:BIOLQ
Biolase — Sidoti Annual NY Micro Cap Conference (January 2013)
21 slides from Biolase's conference presentation, Jan 7, 2013
Slide 1: Fred Furry, COO & CFO, January 7, 2013
Fred Furry, COO & CFO January 7, 2013 Nasdaq: BIOL PAGE EXHIBIT 99.1
Slide 2: Safe Harbor Statement
This presentation may contain forward-looking statements that are based on our current expectations, estimates and projections about our industry as well as management’s beliefs and assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “wil
Slide 3: BIOLASE Company Overview
• We are a biomedical company focused on developing, manufacturing, and selling dental lasers using our revolutionary, proprietary WaterLase technology. • We also market and distribute: – dental imaging equipment, – intra-oral scanners, and – other products designed for dental & medical procedures.
Slide 4: BIOLASE's Total Technology Solution
Step Technology BIOLASE Product Offering Diagnose and establish treatment protocol 3D cone beam imaging • NewTom (QR/Cefla) • DaVinci Imaging (Cefla) Treatment: all tissue surgical device WaterLase • WaterLase iPlus • WaterLase MDX • WaterLase MD Turbo Treatment: soft tissue surgical device Diode la
Slide 5: WaterLase All-Tissue Lasers
• WaterLase is a biological method to cut tissue. • Water molecules within tissue absorb the laser energy from the WaterLase, expand, and vaporize, which causes a biological ablation of the tissue. – There is very little trauma or bleeding, – No heat or vibration are generated, and – Causes little o
Slide 6: How It Works: WaterLase High Speed Cutting
How It Works: WaterLase High Speed Cutting
Slide 7: WaterLase Side by Side with Drill
WaterLase Side by Side with Drill PAGE
Slide 8: WaterLase Soft Tissue Lingual Frenectomy
WaterLase Soft Tissue Lingual Frenectomy PAGE
Slide 9: WaterLase Atraumatic Pediatric Tooth Extraction
WaterLase Atraumatic Pediatric Tooth Extraction The WaterLase aiming beam does not cut the tissue or generate heat. The tissue is cut biologically, with little or no pain, when the laser energizes water at the molecular level.
Slide 10: BIOLASE's Market Opportunity
176,000 dentists in US & Canada. 1.2M+ dentists in 134 countries. – rapid growth in emerging economies e.g. China, India & Indonesia. Current market penetration. – approx. 5.0% of dental practices in US. – approx. 1.5% worldwide. Each incremental 1% market penetration equals over $600M revenue. Dent
Slide 11: Dominant Market Position
80% 45% Dominant Market Position Hard-tissue Dental Laser Market Total Dental Laser Market BIOLASE Market Share
Slide 12: Diode Soft-Tissue Dental Lasers
EPIC 10 total diode solution – regulatory clearance late Q3 (EU) & early Q4 (US) 2012. – cleared for 3 unique uses: Soft Tissue Surgery, Whitening, Pain Therapy. iLase – portable diode laser. – no foot pedal, power cord, or external controls. Diode Soft-Tissue Dental Lasers
Slide 13: In-Licensed Products
TRIOS intra-oral scanner and cart: – digital impression taking. – handheld scanner, operator's control cart, and software. – North American distribution agreement through Aug 2017. In-Licensed Products NewTom and Cefla 3D cone beam imaging products: – medical grade imaging technology. – less cost, l
Slide 14: Extensive Patent Portfolio
Issued & Active Pending Total • 291 patents issued & pending. • 70% are related to WaterLase technology & medical lasers. Extensive Patent Portfolio U.S. International Total
Slide 15: Sales and Marketing
Returned to direct sales model in North America in August 2010. Currently consists of 47-person team: – 37 direct outside sales. – 10 inside sales representatives and lead generators. Targeted plans for 42-45 outside reps and 12-15 inside reps. Global sales offices: – Current: Irvine, CA (USA), Flos
Slide 16: Gross Revenue and Influencers
Gross Revenue and Influencers Launched Cefla’s NewTom Cone Beam Imaging products Introduced iLase™ hand-held soft- tissue diode laser Introduced DaVinci Imaging™ products Launched WaterLase ® iPlus™ all-tissue laser Launched 3Shape’s TRIOS™ intra-oral scanner CE Mark & FDA clearance for EPIC 10 F. P
Slide 17: Gross Revenue Trend Analysis
Gross Revenue Trend Analysis (1) Represents gross revenue for Q2 2012, which does not reflect $1.1 million inventory repurchase from Henry Schein, Inc. (2) Estimated revenue guidance of >$18M for Q4 2012, last revised January 7, 2013. $- $5 $10 $15 $20 Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012
Slide 18: Growth Strategy
• Continued adoption of core laser products. – The WaterLase product line, particularly the iPlus, has demonstrated a solid growth trend over the past 8 quarters. – Significant demad for our EPIC 10 diode soft tissue laser. • Growth of Imaging Division (cone beam and cad-cam). • Additional new produ
Slide 19: Investment Considerations
• Ongoing growth in core WaterLase sales and trend of adoption. • High demand for our new EPIC 10 soft tissue diode laser. • Recent & planned new product introductions. – EPIC 10 & TRIOS introduced second half of 2012. – Additional product launches based on core technologies planned for 2013 and bey
Slide 20: BIOLASE Today
• Over 180 employees worldwide. • Sales offices in Floss (Germany), Madrid (Spain), Shanghai (China), and Mumbai (India); expansion planned in Dubai (UAE), and Rio de Janero (Brazil). • Floss also has service and manufacturing capabilities. BIOLASE Europe in Floss, Germany • Corporate HQ: Irvine, Ca
Slide 21: Fred Furry, COO & CFO, BIOLASE, Inc.
Fred Furry COO & CFO, BIOLASE, Inc. 949.226.8124 ffurry@biolase.net PAGE Lisa Wilson President, In-Site Communications, Inc. 212.759.3929 lwilson@insitecony.com
Biolase — Sidoti Annual NY Micro Cap Conference (January 2013) on 6ix